折叠式人工玻璃体治疗严重视网膜脱离的有效性与安全性评价
前瞻性、多中心、单臂Ⅱ期临床试验纳入26例严重视网膜脱离伴早期眼球萎缩患者,行玻璃体切除联合折叠式人工玻璃体植入,平均随访33个月。24只眼视网膜复位,眼球萎缩均得以控制,16例基线眼球萎缩患者末次眼压显著高于术前,未见明显不良反应,但视力提高有限。
要点
- 24只眼视网膜复位,所有患者眼球萎缩得以控制,未见明显不良反应。
- 16例基线眼球萎缩患者末次眼压(14.6±3.9)mmHg显著高于术前(8.5±2.4)mmHg(t=-5.326,P<0.001)。
- 4例(15.4%)视力高于术前,5例(19.2%)无改变,视力提高有限。
核心结论
- 折叠式人工玻璃体植入是治疗严重视网膜脱离伴早期眼球萎缩的安全有效途径,可复位视网膜、控制眼球萎缩、维持眼球外形和眼压,但术后视力无提高。
研究设计与样本
- 前瞻性、多中心、单臂Ⅱ期临床试验,纳入2011年4月至2012年7月北京同仁眼科中心严重视网膜脱离伴早期眼球萎缩患者26例,均单眼纳入(左右眼各13只),年龄(37.5±11.5)岁,平均随访33个月。
主要发现
- 24只眼视网膜复位,所有患者眼球萎缩得以控制。
- 4例(15.4%)患者术后视力高于术前,5例(19.2%)较术前无改变。
- 末次随访平均眼压(14.4±3.9)mmHg高于基线(12.0±6.5)mmHg,差异无统计学意义(Z=-1.859,P=0.063)。
- 16例眼球萎缩患者患眼末次平均眼压(14.6±3.9)mmHg显著高于术前(8.5±2.4)mmHg(t=-5.326,P<0.001)。
- 未见明显不良反应。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To determine the efficacy and safety of vitrectomy combined with implantation of a foldable capsular vitreous body in the treatment of severe retinal detachment with early ocular atrophy in human eyes. Methods: This study was a prospective, multicenter, and one-arm phase Ⅱ clinical trial. Patients with severe retinal detachment and early eyeball atrophy attending Beijing Tongren Eye Center from April 2011 to July 2012 were included. A standard three-port pars plana vitrectomy was performed, and a foldable capsular vitreous body was folded and sent into the vitreous cavity; silicone oil was injected into the capsule. Measurement of visual acuity and intraocular pressure, corneal endothelium count, color fundus photography, optical coherence tomography, and ocular ultrasonography were performed to observe retinal reattachment and adverse reactions after surgery. Wilcoxon signed rank test was performed to compare the baseline and postoperative visual acuity, intraocular pressure and corneal endothelium count. Results: A total of 26 patients were enrolled, including 23 males and 3 females. The age was (37.5±11.5) years, with an average follow-up of 33 months. For each patient, only the left or right eye was included (13 left eyes and 13 right eyes). Retinal reattachment was found in all 24 eyes, and the eyeball atrophy was controlled in all patients. Visual acuity was improved in 4 patients (15.4%) and unchanged in 5 patients (19.2%). The mean intraocular pressure [(14.4±3.9) mmHg(1 mmHg=0.133 kPa)] at the last follow-up was higher than the baseline intraocular pressure [(12.0±6.5) mmHg], but the difference was not statistically significant (Z=-1.859, P=0.063). For the 16 patients with ocular atrophy at baseline, the last follow-up intraocular pressure [(14.6±3.9) mmHg] was significantly higher than the preoperative intraocular pressure [(8.5±2.4) mmHg] (t=-5.326, P<0.001). No obvious adverse reactions were observed. Conclusions: Implantation of a foldable capsular vitreous body is an effective way to treat severe retinal detachment with early eyeball atrophy. It can help to reattach the retina, control eyeball atrophy, maintain the eye shape and intraocular pressure, while visual acuity improvement is limited. (Chin J Ophthalmol, 2019, 55: 259-266). 目的: 探讨玻璃体切除联合折叠式人工玻璃体植入术治疗严重视网膜脱离伴早期眼球萎缩的有效性和安全性。 方法: 前瞻性、多中心、单臂Ⅱ期临床试验。选择2011年4月至2012年7月就诊于北京同仁眼科中心门诊的严重视网膜脱离、有早期眼球萎缩特征的患者。进行常规三通道玻璃体切除术,将折叠式人工玻璃体折叠并植入玻璃体腔,囊袋内硅油填充。术后定期随访,检查视力、眼压、角膜内皮计数、彩色眼底像、相干光层析成像术、眼部B超等检查,观察视网膜复位情况及术后不良反应。对患者的基线和末次随访视力、眼压、角膜内皮计数、眼轴长度等结果进行正态性检验,符合正态分布的数据采用配对t检验进行统计学比较,不符合正态分布则采用Wilcoxon配对秩和检验。 结果: 共纳入患者26例,其中男性23例,女性3例,年龄(37.5±11.5)岁,平均随访33个月。均单眼纳入研究,左右眼各13只。24只眼视网膜复位,眼球萎缩得以控制,4例(15.4%)患者术后视力高于术前,5例(19.2%)患者较术前无改变。术后末次随访平均眼压(14.4±3.9)mmHg(1 mmHg=0.133 kPa),高于基线眼压(12.0±6.5)mmHg,但差异无统计学意义(Z=-1.859,P=0.063),16例眼球萎缩患者患眼末次平均眼压(14.6±3.9)mmHg,显著高于患眼术前的(8.5±2.4)mmHg(t=-5.326,P<0.001),未见明显不良反应。 结论: 折叠式人工玻璃体植入是治疗严重视网膜脱离、早期眼球萎缩的安全有效途径,可以复位视网膜,控制眼球萎缩,维持眼球外形和眼压,但术后视力无提高。(中华眼科杂志,2019,55:259-266).
引用
- Yan YN, Tian B, Liu Q, et al. [Evaluation of the efficacy and safety of a foldable capsular vitreous body in the treatment of severe retinal detachment]. Zhonghua Yan Ke Za Zhi. 2019. PMID: 30982287. doi:10.3760/cma.j.issn.0412-4081.2019.04.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。